APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

Age-dependent effects ofAPOEε4 in preclinical Alzheimer's disease

(2016) Luke W. Bonham et al.   Annals of Clinical and Translational Neurology

The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study

(2015) Renée FAG de Bruijn et al.   BMC Medicine

The Rotterdam Study: 2016 objectives and design update

(2015) Albert Hofman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

(2015) Tiia Ngandu et al.   LANCET

CAP—advancing the evaluation of preclinical Alzheimer disease treatments

(2015) Eric M. Reiman et al.   Nature Reviews Neurology

Spectrum of cognition short of dementia

(2015) David S. Knopman et al.   NEUROLOGY

Apolipoprotein E in Alzheimer's Disease: An Update

(2014) Jin-Tai Yu et al.   Annual Review of Neuroscience

The A4 Study: Stopping AD Before Symptoms Begin?

(2014) R. A. Sperling et al.   Science Translational Medicine

Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences

(2014) Michelle Mielke et al.   Clinical Epidemiology

Overview and Findings from the Religious Orders Study

(2013) David A. Bennett et al.   Current Alzheimer Research

Virgin olive oil supplementation and long-term cognition: the Predimed-Navarra randomized, trial

(2013) Elena H. Martinez-Lapiscina et al.   Journal of Nutrition Health & Aging

Competing risks in epidemiology: possibilities and pitfalls

(2012) Per Kragh Andersen et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Applying competing risks regression models: an overview

(2012) Bernhard Haller et al.   LIFETIME DATA ANALYSIS

Communicating Genetic Risk Information for Common Disorders in the Era of Genomic Medicine

(2011) Denise M. Lautenbach et al.   Annual Review of Genomics and Human Genetics

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics

(2011) JS Roberts et al.   CLINICAL GENETICS

Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors

(2011) Jill S Goldman et al.   GENETICS IN MEDICINE

Helping Patients Decide: Ten Steps to Better Risk Communication

(2011) A. Fagerlin et al.   JNCI-Journal of the National Cancer Institute

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

(2011) E Genin et al.   MOLECULAR PSYCHIATRY

Effect of Different Impairment Criteria on Prevalence of “Objective” Mild Cognitive Impairment in a Community Sample

(2010) Nicole A. Kochan et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

(2010) Eric M Reiman et al.   Biomarkers in Medicine

The Alzheimerʼs Disease Centersʼ Uniform Data Set (UDS)

(2009) Sandra Weintraub et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

(2009) Jean-Charles Lambert et al.   NATURE GENETICS